We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Allergan Plc | LSE:0Y7T | London | Ordinary Share | IE00BY9D5467 | ALLERGAN ORD SHS |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.00% | 154.21 | 0.00 | 01:00:00 |
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| 0 | 0 | N/A | 0 |
TIDM0Y7T
RNS Number : 6205M
Societe Generale SA
12 May 2020
Ap19
FORM 8.3 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
Hot Features
Premium
1. KEY INFORMATION
Name of person dealing Société Générale
(Note 1) S.A.
Company dealt in Allergan plc
====================================
Class of relevant security US$0.0001 ordinary shares
to which the dealings
being disclosed relate
(Note 2)
====================================
Date of dealing 11/05/2020
====================================
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Long Short
Number (%) Number (%)
-------- ----- -------- -----
(1) Relevant securities 118,491 0.04 106,309 0.03
-------- ----- -------- -----
(2) Derivatives (other
than options) 0 0.00 0 0.00
-------- ----- -------- -----
(3) Options and agreements
to purchase/sell 0 0.00 0 0.00
-------- ----- -------- -----
Total 118,491 0.04 106,309 0.03
-------- ----- -------- -----
(b) Interests and short positions in relevant securities of the company, other than the class dealt
in (Note 3)
Class of relevant Long Short
security:
Number (%) Number (%)
------- ---- ------- ----
(1) Relevant securities
------- ---- ------- ----
(2) Derivatives
(other than options)
------- ---- ------- ----
(3) Options and
agreements to purchase/sell
------- ---- ------- ----
Total
------- ---- ------- ----
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant Price per unit
securities USD (Note 5)
Purchase 2,985 120.3
------------------- ---------------
Purchase 14,000 120.3
------------------- ---------------
Purchase 1,300 120.3
------------------- ---------------
Purchase 4,085 120.3
------------------- ---------------
Purchase 168 120.3
------------------- ---------------
Purchase 5 120.3
------------------- ---------------
Purchase 4,789 120.3
------------------- ---------------
Purchase 433 120.3
------------------- ---------------
Purchase 653 120.3
------------------- ---------------
Purchase 164 120.3
------------------- ---------------
Purchase 267 120.3
------------------- ---------------
Purchase 358 120.3
------------------- ---------------
Purchase 43,405 120.3
------------------- ---------------
Purchase 1 120.3
------------------- ---------------
Purchase 5 120.3
------------------- ---------------
Purchase 2,687 120.3
------------------- ---------------
Purchase 46,504 120.3
------------------- ---------------
Purchase 8,602 120.3
------------------- ---------------
Purchase 7,888 120.3
------------------- ---------------
Purchase 3,385 120.3
------------------- ---------------
Purchase 77 120.3
------------------- ---------------
Purchase 6 120.3
------------------- ---------------
Purchase 10,100 120.3
------------------- ---------------
Purchase 6,880 120.3
------------------- ---------------
Purchase 10 120.3
------------------- ---------------
Purchase 133 120.3
------------------- ---------------
Purchase 428 120.3
------------------- ---------------
Purchase 2 120.3
------------------- ---------------
Purchase 3,438 120.3
------------------- ---------------
Purchase 209 120.3
------------------- ---------------
Purchase 959 120.3
------------------- ---------------
Purchase 32 120.3
------------------- ---------------
Purchase 1,815 120.3
------------------- ---------------
Purchase 32,278 120.3
------------------- ---------------
Purchase 66 120.3
------------------- ---------------
Purchase 105 120.3
------------------- ---------------
Purchase 7,966 120.3
------------------- ---------------
Purchase 8,000 120.3
------------------- ---------------
Purchase 571 120.3
------------------- ---------------
Purchase 9,000 120.3
------------------- ---------------
Purchase 4,562 120.3
------------------- ---------------
Purchase 5,990 120.3
------------------- ---------------
Purchase 33 120.3
------------------- ---------------
Purchase 146 120.3
------------------- ---------------
Purchase 194,082 120.3
------------------- ---------------
Purchase 1,500 120.3
------------------- ---------------
Purchase 2 120.3
------------------- ---------------
Purchase 66 120.3
------------------- ---------------
Purchase 143 120.3
------------------- ---------------
Purchase 3,900 120.3
------------------- ---------------
Purchase 13,000 120.3
------------------- ---------------
Purchase 18 120.3
------------------- ---------------
Purchase 373 120.3
------------------- ---------------
Purchase 40,361 120.3
------------------- ---------------
Purchase 6 120.3
------------------- ---------------
Purchase 3,114 120.3
------------------- ---------------
Sale 18,738 120.3
------------------- ---------------
Sale 345 120.3
------------------- ---------------
Sale 26,961 120.3
------------------- ---------------
Sale 498 120.3
------------------- ---------------
Sale 2,369 120.3
------------------- ---------------
Sale 13 120.3
------------------- ---------------
Sale 47 120.3
------------------- ---------------
Sale 7,203 120.3
------------------- ---------------
Sale 1,132 120.3
------------------- ---------------
Sale 3,600 120.3
------------------- ---------------
Sale 10 120.3
------------------- ---------------
Sale 8,825 120.3
------------------- ---------------
Sale 16 120.3
------------------- ---------------
Sale 48,971 120.3
------------------- ---------------
Sale 31,211 120.3
------------------- ---------------
Sale 2,655 120.3
------------------- ---------------
Sale 3,260 120.3
------------------- ---------------
Sale 9 120.3
------------------- ---------------
Sale 273 120.3
------------------- ---------------
Sale 6 120.3
------------------- ---------------
Sale 30 120.3
------------------- ---------------
Sale 423 120.3
------------------- ---------------
Sale 9,000 120.3
------------------- ---------------
Sale 112,504 120.3
------------------- ---------------
Sale 6,812 120.3
------------------- ---------------
Sale 16 120.3
------------------- ---------------
Sale 200,000 120.3
------------------- ---------------
Sale 18,222 120.3
------------------- ---------------
Sale 478 120.3
------------------- ---------------
Sale 402 120.3
------------------- ---------------
Sale 258 120.3
------------------- ---------------
Sale 209 120.3
------------------- ---------------
Sale 75,090 120.3
------------------- ---------------
Sale 269 120.3
------------------- ---------------
Sale 3 120.3
------------------- ---------------
Sale 283 120.3
------------------- ---------------
Sale 40,400 120.3
------------------- ---------------
Sale 32,278 120.3
------------------- ---------------
Sale 41 120.3
------------------- ---------------
Sale 77 120.3
------------------- ---------------
Sale 72 120.3
------------------- ---------------
Sale 10,100 120.3
------------------- ---------------
Sale 305,200 120.3
------------------- ---------------
Sale 394 120.3
------------------- ---------------
Sale 780 120.3
------------------- ---------------
Sale 6 120.3
------------------- ---------------
Sale 358 120.3
------------------- ---------------
Sale 15 120.3
------------------- ---------------
Sale 86,782 120.3
------------------- ---------------
Sale 1,008 120.3
------------------- ---------------
Sale 127 120.3
------------------- ---------------
Sale 2,016 120.3
------------------- ---------------
Sale 7,999 120.3
------------------- ---------------
Sale 87 120.3
------------------- ---------------
Sale 1,202 120.3
------------------- ---------------
Sale 62 120.3
------------------- ---------------
Sale 39 120.3
------------------- ---------------
Sale 40,719 120.3
------------------- ---------------
Sale 352 120.3
------------------- ---------------
Sale 375 120.3
------------------- ---------------
Sale 15 120.3
------------------- ---------------
Sale 910 120.3
------------------- ---------------
Sale 1,195 120.3
------------------- ---------------
Sale 14,783 120.3
------------------- ---------------
Sale 5,986 120.3
------------------- ---------------
Sale 6,329 120.3
------------------- ---------------
Sale 237,700 120.3
------------------- ---------------
Sale 314 120.3
------------------- ---------------
Sale 139 120.3
------------------- ---------------
Sale 1 120.3
------------------- ---------------
Sale 19,000 120.3
------------------- ---------------
Sale 468,700 120.3
------------------- ---------------
Sale 101 120.3
------------------- ---------------
Sale 99 120.3
------------------- ---------------
Sale 87 120.3
------------------- ---------------
Sale 15,285 120.3
------------------- ---------------
Sale 7,649 120.3
------------------- ---------------
Sale 62,600 120.3
------------------- ---------------
Sale 1,856 120.3
------------------- ---------------
Sale 20 120.3
------------------- ---------------
Sale 19,900 120.3
------------------- ---------------
Sale 2,685 120.3
------------------- ---------------
Sale 1,144 120.3
------------------- ---------------
Sale 3 120.3
------------------- ---------------
Sale 446 120.3
------------------- ---------------
Sale 96 120.3
------------------- ---------------
Sale 358 193.02
------------------- ---------------
Total Purchases 491,055
------------------- ---------------
Total Sales 1,978,031
------------------- ---------------
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant Price per
e.g. CFD (Note 6) securities unit USD
(Note 7) (Note 5)
-------------- ---------------------- ------------------ ----------
CFD Closing short 86,782 120.30
---------------------- ------------------ ----------
CFD Closing short 40,719 120.30
---------------------- ------------------ ----------
CFD Closing short 910 120.30
---------------------- ------------------ ----------
CFD Closing short 1,195 120.30
---------------------- ------------------ ----------
CFD Closing short 15,285 120.30
---------------------- ------------------ ----------
Equity Linked
Swap Closing short 468,700 120.30
---------------------- ------------------ ----------
Equity Linked
Swap Closing short 305,200 120.30
---------------------- ------------------ ----------
Equity Linked Expiry 200,000 N/A
Swap
---------------------- ------------------ ----------
Equity Linked Expiry 237,700 N/A
Swap
---------------------- ------------------ ----------
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product Writing, Number of Exercise Type, Expiry Option
name, selling, securities price e.g. American, date money
e.g. call purchasing, to which European paid/received
option varying the option etc. per unit
etc. relates (Note (Note
7) 5)
Listed
put-option Purchasing 18,500 190 American 15/01/2021 0
============= ============== ======== =============== ========== ==============
Listed
put-option Purchasing 40,000 175 American 15/01/2021 0
============= ============== ======== =============== ========== ==============
(ii) Exercising
Product name, Number of securities Exercise price
e.g. call option per unit (Note
5)
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction Details Price per unit
(Note 8) (if applicable)
(Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
Is a Supplemental Form 8 attached? (Note 9) No
Date of disclosure 12/05/2020
Contact name Société Générale
- Disclosure team
====================================
Telephone number +33 1 42 14 92 74
====================================
If a connected EFM, name
of offeree/offeror with
which connected
====================================
If a connected EFM, state
nature of connection (Note
10)
====================================
Ap23
SUPPLEMENTAL FORM 8 IRISH TAKEOVER PANEL DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013 DETAILS OF OPEN POSITIONS
(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3,
as appropriate)
OPEN POSITIONS (Note 1)
Product Written, Number of relevant Exercise Type, Expiry
name, or purchased securities price e.g. American, date
e.g. call to which the (Note European
option option or derivative 2) etc.
relates
Notes
1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be
given on this form. 2. For all prices and other monetary amounts, the currency must be stated. For full details of disclosur e requirements, see Rule 8 of the
Rules. If in doubt, consult the Panel.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
END
ISEKKBBQOBKKPPD
(END) Dow Jones Newswires
May 12, 2020 03:48 ET (07:48 GMT)
1 Year Allergan Chart |
1 Month Allergan Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
